MENU
GANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gain Therapeutics (GANX) Earnings Date & Reports

A.I. Advisor
published Earnings

GANX is expected to report earnings to rise 20.35% to -20 cents per share on March 20

Gain Therapeutics GANX Stock Earnings Reports
Q4'24
Est.
$-0.20
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.23
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.04
The last earnings report on November 14 showed earnings per share of -17 cents, beating the estimate of -20 cents. With 156.02K shares outstanding, the current market capitalization sits at 44.56M.
View a ticker or compare two or three
GANX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4800 Montgomery Lane
Phone
+1 301 500-1556
Employees
32
Web
https://www.gaintherapeutics.com